Boehringer’s STIOLTO RESPIMAT Shows Promising Results Clinical Trials
COPD, News
Post-hoc analysis of the TONADO and OTEMTO trials of the 15,000-patient phase III Chronic Obstructive Pulmonary Disease (COPD) clinical trial TOviTO assessing Boehringer Ingelheim‘s STIOLTO RESPIMAT’s efficacy and safety in COPD were recently ... Read more